Indication intelligence, analysis and sector perception

RegMed Investors’ (RMI) Earnings: dates of releases and more results

August 9, 2022

Upcoming Q2 earnings announcements … 29 of 35 reported so far Agenus (AGEN),Avrobio (AVRO), Beam Therapeutics (BEAM), Caribou Biosciences (CRBU), Ionis Pharmaceuticals (IONS) and Verve Therapeutics (VERV) and Biolife Solutions (BLFS) reported Tuesday, 8/9 Brainstorm Cell Therapeutics (BCLI) on Monday, 8/15   Results are listed below ...

Verve Therapeutics (VERV) proposes $200 M offering priced at $27.00

July 21, 2022

VERV’s 8.3 M share offering has been priced at $27.00 with a -$6.01 or -16.74% drop in pre-market;  Wednesday’s +$3.62, Tuesday’s +$5.98 and Monday’s +$2.60 following Friday’s -$0.49, Thursday’s -$0.97 and last Wednesday’s +$2.97 and the previous Tuesday’s +$1.72), J.P. Morgan, Jefferies, Guggenheim Securities and William Blair are acting as joint book-running managers for the offering.

Applied Genetic Technologies (AGTC) prices public offering of 16,66 M shares at $0.60

July 13, 2022

Trading -$0.45 or -52.67% to $0.40 in the a.m.  Closed down -$0.011 to $0.847 with an aftermarket of -$0.26 or -30.38% to $0.59   What a JOKE, actually a travesty for investors!